Display Settings:

Format

Send to:

Choose Destination

    Drug-induced acute cholestatic liver damage in a patient with mutation of UGT1A1.

    Source

    Centro Studi Fegato, AREA Science Park, Basovizza, Trieste, Italy. igino.rigato@csf.units.it

    Abstract

    BACKGROUND:

    A 54-year-old woman presented with a 3-week history of fatigue and with jaundice that began 2 days before admission. She had been undergoing treatment with flavoxate for urinary incontinence (for 2 months before admission) and with tibolone for climacteric syndrome (for 6 months before admission). Laboratory tests revealed elevated concentrations of aminotransferases, bilirubin, gamma-glutamyltransferase and alkaline phosphatase. Liver biopsy revealed histological evidence of subacute, drug-induced liver damage.

    INVESTIGATIONS:

    Physical examination, liver function tests, serology tests, autoantibody tests, genetic analysis of the TATA box of the UGT1A1 gene, ultrasonography and CT scan; MRI cholangiography; liver biopsy.

    DIAGNOSIS:

    Drug-related hepatitis in a patient with Gilbert's syndrome.

    MANAGEMENT:

    Flavoxate and tibolone were discontinued. Liver function test results improved progressively and normalized after almost 2 months.

    PMID:
    17607296
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Nature Publishing Group

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk